Learn More
Medchemexpress LLC Pazopanib (GW786034) | 444731-52-6 | MFCD11616589 | 99.9% | 437.52 g/mol | C21H23N7O2S | 200 MG

Supplier: Medchemexpress LLC HY10208200MG
Pazopanib (GW786034) is a small-molecule, multi-target tyrosine kinase inhibitor provided as a research-grade solid. It potently inhibits VEGFR1, VEGFR2, and VEGFR3 and shows activity against PDGFRβ, c-Kit, FGFR1, and c-Fms, with reported IC50 values in the low nanomolar range; it also inhibits VEGF-induced proliferation and VEGFR-2 phosphorylation in HUVEC cells.
- Multi-target VEGFR/PDGFR tyrosine kinase inhibitor
- Potent enzyme inhibition with IC50s: VEGFR1 10 nM, VEGFR2 30 nM, VEGFR3 47 nM
- Cellular activity: inhibits VEGF-induced proliferation and VEGFR-2 phosphorylation (~8 nM)
- High purity (99.9%) solid suitable for research applications
- Available in research packaging sizes including 200 mg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.